Norges Bank’s TherapeuticsMD TXMD Stock Holding History

Norges Bank’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,048	Closed	-$753K	–	2164
2020 Q2	$753K	Sell	12,048 -2,281	-16%	-$133K	﹤0.01%	2029
2020 Q1	$759K	Hold	14,329	–	–	﹤0.01%	1997
2019 Q4	$1.73M	Hold	14,329	–	–	﹤0.01%	1993
2019 Q3	$2.6M	Hold	14,329	–	–	﹤0.01%	1970
2019 Q2	$1.86M	Hold	14,329	–	–	﹤0.01%	2008
2019 Q1	$3.49M	Hold	14,329	–	–	﹤0.01%	1973
2018 Q4	$2.73M	Hold	14,329	–	–	﹤0.01%	1979
2018 Q3	$4.7M	Buy	14,329 +5,000	+54%	+$1.53M	﹤0.01%	1975
2018 Q2	$2.91M	Sell	9,329 -11,109	-54%	-$3.39M	﹤0.01%	2004
2018 Q1	$4.98M	Hold	20,438	–	–	﹤0.01%	1896
2017 Q4	$6.17M	Hold	20,438	–	–	﹤0.01%	1845
2017 Q3	$5.41M	Hold	20,438	–	–	﹤0.01%	1854
2017 Q2	$5.39M	Sell	20,438 -8,196	-29%	-$2.05M	﹤0.01%	1871
2017 Q1	$10.3M	Hold	28,634	–	–	﹤0.01%	1733
2016 Q4	$8.26M	Hold	28,634	–	–	﹤0.01%	1755
2016 Q3	$9.31M	Buy	28,634 +9,918	+53%	+$3.62M	﹤0.01%	1690
2016 Q2	$7.95M	Buy	18,716 +3,360	+22%	+$1.38M	﹤0.01%	1720
2016 Q1	$4.91M	Buy	15,356 +2,000	+15%	+$682K	﹤0.01%	1839
2015 Q4	$6.92M	Buy	13,356 +11,281	+544%	+$4.16M	﹤0.01%	1772
2015 Q3	$608K	Buy	+2,075	New	+$738K	﹤0.01%	2168

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Norges Bank's TXMD Position: Q3 2020 in Review

Norges Bank sold out of TherapeuticsMD (TXMD) in Q3 2020, closing a stake of 12,048 shares — an estimated $753K sold.

Norges Bank first reported a position in TXMD in Q3 2015 and held it in 20 quarters. The position peaked at $10.3M in Q1 2017. 142 funds tracked by Wall St. Rank hold TXMD as of Q3 2020.

Norges Bank reported no remaining TherapeuticsMD position as of Q3 2020 after selling out during the quarter.
Norges Bank sold 12,048 TherapeuticsMD shares in Q3 2020, an estimated $753K.
Norges Bank first reported a position in TherapeuticsMD in Q3 2015 and held it in 20 quarters.
Norges Bank's TherapeuticsMD position peaked at $10.3M in Q1 2017.
142 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2020.

Based on Norges Bank's 13F filing for Q3 2020, filed 10 Nov 2020.